Special situation: Nektar Therapeutics (NKTR - 18.21)
Article Abstract:
A profile of Nektar Therapeutics, drug delivery systems developer, is presented. Analysis of stocks of Nektar is done based on the information available as of June 23, 2006. The stocks of the company are expected to register good income as well as growth in a 3 to 5 years time frame.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Special situation: Nektar Therapeutics (NKTR - 18.21)
Article Abstract:
A profile of Nektar Therapeutics, drug delivery systems developer, is presented. Analysis of stocks of Nektar is done based on the information available as of June 23, 2006. The stocks of the company are expected to register good income as well as growth in a 3 to 5 years time frame.
Publication Name: The Value Line Investment Survey (Part 2 - Selection & Opinion)
Subject: Business, general
ISSN:
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Nektar Therap'tics
Article Abstract:
The price appreciation potential of the shares of Nektar Therapeutics for the years 2010-2012 is discussed. The San Carlos, California-based company researches and develops drug-delivery systems for the administration of peptides, proteins, and other molecules.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Stock highlight: Motorola, Inc. (MOT - 20.68). Retail automotive industry. Electric utility (west) industry
- Abstracts: Selection for growth: Bed Bath & Beyond (BBBY - 41.51). Avnet. Selection for growth: Avnet, Inc. (AVT - 25.06)
- Abstracts: Selection for growth: Korn/Ferry Int'l (KFY - 20.66). Korn/Ferry Int'l. Stock highlight: Amn Healthcare (AHS - 27.29)
- Abstracts: Selection for growth: Macdermid Inc. (MRD - 29.52). Stock highlight: DuPont (DD-47.20). Chemical (specialty)